Senior Biotech R&D execs brainstorm on saving clinical trials, modifying procedures, and getting people back to work.
The pharma and healthcare sector faces a serious threat of operational challenges due to COVID-19. Operations leaders gather to discuss how to move forward.
As Contract Development and Manufacturing Organizations (CDMOs) in the BioPharma space have boomed and broadened their capabilities in recent years, they have entered a more complex era that presents a host of new challenges.
As financial pressure on payers has increased, and evidence-based pricing moves up the agenda, market access has become one of the single biggest challenges pharmaceuticals companies face.